Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings

Shares (Q2 2026)
157
Value
$3.97K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ACAD by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026157$3.97K<0.1%+115+273.8%AddedHolders
Q1 202642$935<0.1%00.0%UnchangedHolders
Q4 202542$1.12K<0.1%−16−27.6%ReducedHolders
Q3 202558$1.24K<0.1%+16+38.1%AddedHolders
Q2 202542$906<0.1%−65−60.7%ReducedHolders
Q1 2025107$1.78K<0.1%−34−24.1%ReducedHolders
Q4 2024141$2.59K<0.1%+83+143.1%AddedHolders
Q3 202458$892<0.1%+58NewHolders
Q2 20240$00.0%−194−100.0%Sold outHolders
Q1 2024194$3.59K<0.1%00.0%UnchangedHolders
Q4 2023194$6.07K<0.1%−130−40.1%ReducedHolders
Q3 2023324$6.75K<0.1%+162+100.0%AddedHolders
Q2 2023162$3.88K<0.1%00.0%UnchangedHolders
Q1 2023162$3.05K<0.1%00.0%UnchangedHolders
Q4 2022162$2.58K<0.1%−92−36.2%ReducedHolders
Q3 2022254$4.00K<0.1%+81+46.8%AddedHolders
Q2 2022173$2.00K<0.1%−321−65.0%ReducedHolders
Q1 2022494$12.0K<0.1%−871−63.8%ReducedHolders
Q4 20211,365$32.0K<0.1%+584+74.8%AddedHolders
Q3 2021781$13.0K<0.1%+461+144.1%AddedHolders
Q2 2021320$8.00K<0.1%+44+15.9%AddedHolders
Q1 2021276$7.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.